Interaction of verapamil with human platelet alpha-adrenergic receptors.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  American Journal of Physiology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1152/AJPHEART.1982.242.1.H19PMID 6277203
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating Platelet Products in Unstable Angina Pectoris

  1981cited by this paper
• alpha-adrenergic antagonists as possible calcium channel inhibitors.

  1981cited by this paper
• Coronary artery spasm as a cause of myocardial ischemia.

  1981cited by this paper
• A controlled trial of verapamil for Prinzmetal's variant angina.

  1981cited by this paper
• Characterization of alpha-adrenergic receptors in human platelets using [3H]clonidine.

  1981cited by this paper
• Calcium- and potassium-channel blockers interact with alpha-adrenoceptors.

  1980cited by this paper
• The involvement of calcium in epinephrine or ADP potentiation of human platelet aggregation.

  1980cited by this paper
• Epinephrine induces Ca2+ uptake in human blood platelets.

  1980cited by this paper
• Heterogeneity of radioligand binding to alpha-adrenergic receptors. Analysis of guanine nucleotide regulation of agonist binding in relation to receptor subtypes.

  1980cited by this paper
• Characterization of alpha 2-adrenergic receptors on human platelets using [3H]yohimbine.

  1980cited by this paper
• Verapamil and Norverapamil Plasma Concentrations During Long‐Term Therapy in Patients with Hypertrophic Obstructive Cardiomyopathy

  1980cited by this paper
• Interactions of D600 (methoxyverapamil) and local anesthetics with rat brain alpha-adrenergic and muscarinic receptors.

  1980cited by this paper
• alpha-Adrenergic blockade and inhibition of A23187 mediated Ca2+ uptake by the calcium antagonist verapamil in rat liver cells.

  1979cited by this paper
• Altered adrenergic activity in coronary arterial spasm: insight into mechanism based on study of coronary hemodynamics and the electrocardiogram.

  1979cited by this paper
• Pharmacokinetics of verapamil in man.

  1979cited by this paper
• Platelet function in essential thrombocythemia. Decreased epinephrine responsiveness associated with a deficiency of platelet alpha-adrenergic receptors.

  1978cited by this paper
• Relationships between membrane cholesterol, alpha-adrenergic receptors, and platelet function.

  1978cited by this paper
• Coronary-artery spasm.

  1978cited by this paper
• Identification of alpha-adrenergic receptors in human platelets by [3H]dihydroergocryptine binding.

  1978cited by this paper
• Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.

  1977cited by this paper
• Platelet hypersensitivity induced by cholesterol incorporation.

  1975cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper
• A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function.

  1972cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Potential Protective Role of Blood Pressure-Lowering Drugs on the Balance between Hemostasis and Fibrinolysis in Hypertensive Patients at Rest and During Exercise

  2019cites this paper
• Electrogenic Na+/Ca2+-exchange of nerve and muscle cells.

  2007cites this paper
• Acquired platelet dysfunction.

  2007cites this paper
• Evaluation of platelet function in aspirin treated patients with CAD

  2006cites this paper
• CALCIUM ANTAGONISTS Disparate effects of the calcium-channel blockers , nifedipine and verapamil , on a 2-adrenergic receptors and thromboxane A 2-induced aggregation of human platelets

  2005cites this paper
• Interaction of Verapamil and Other Calcium Channel Blockers with ax-and a 2-Adrenergic Receptors

  2005cites this paper
• Quin 2 Microfluorometry and Effects of Verapamil and Diltiazem on Calcium Release From Rat Aorta Smooth Muscle Cells in Primary Culture

  2005cites this paper
• The effects of antihypertensive therapy on haemostatic parameters.

  2003cites this paper
• Activation of platelet gpIIbIIIa by phospholipase C from Clostridium perfringens involves store-operated calcium entry.

  2003cites this paper
• Anemia During the Late Postoperative Period Following Cardiopulmonary Bypass Surgery

  1998cites this paper
• Calcium antagonist treatment, sympathetic activity and platelet function.

  1997cites this paper
• Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function. Possible importance for the treatment of unstable angina.

  1997cites this paper
• Transesophageal echocardiography in the detection of inferior vena cava and cardiac metastasis in hepatocellular carcinoma

  1996cites this paper
• Tetrandrine differentially inhibits aggregation and ATP-release of rat platelets.

  1996cites this paper
• Stress‐induced hemodynamic and hemostatic changes in patients with systemic hypertension: Effect of verapamil

  1996cites this paper
• Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris.

  1995cites this paper
• Effects of gallopamil on epinephrine and norepinephrine plasmatic levels and on TxB2 and beta-tg release in patients with coronary artery disease during adrenergic stimulus with cold pressor test.

  1995cites this paper
• Effects of diltiazem and verapamil on ADP-induced rabbit platelet shape change and aggregation.

  1995cites this paper
• Calcium Channel Antagonists Reduce the Cocaine‐Induced Decrease in Cardiac Output in a Subset of Rats

  1993cites this paper
• Effects of Rilmenidine and Hydrochlorothiazide on Human Platelet α2-Adrenoceptors

  1993cites this paper
• Bedeutung von Kalziumionen und Kalziumantagonisten bei affektiven Psychosen

  1992cites this paper
• Long-term treatment with different calcium- and calmodulin-antagonists induces changes in rat brain alpha-adrenoceptors.

  1992cites this paper
• Effects of calcium and calcium-channel blocker methoxyverapamil on the beta-adrenoceptors in myocardial cells in vitro.

  1992cites this paper
• [Platelet receptors: nomenclature--structure--function. 2].

  1992cites this paper
• Effect of Calcium Channel Blockers on Platelet GPIIb-IIIa as a Calcium Channel in Liposomes: Comparison with Effects on the Intact Platelet

  1992cites this paper
• Effect of Calcium Channel Blocking Agents on Infarct Size After Ischaemia‐Reperfusion in Anaesthetised Pigs: Relationship Between Cardioprotection and Cardiodepression

  1991cites this paper
• In vitro effects of two novel calcium antagonists (nitrendipine and nisoldipine) on intraplatelet calcium redistribution, platelet aggregation and thromboxane A2 formation. Comparison with diltiazem, nifedipine and verapamil.

  1991cites this paper
• Effect of nifedipine on the progression of coronary atherosclerosis in humans. Analysis of coronary angiogram by videodensitometry.

  1991cites this paper
• Effects of diltiazem on calcium concentrations in the cytosol and on force of contractions in porcine coronary arterial strips

  1990cites this paper
• Adenosine potentiates the inhibitory effects of calcium channel antagonists on human platelet aggregation induced by thromboxane A2 or U46619.

  1990cites this paper
• Reduction of Intimal Hyperplasia and Enhanced Reactivity of Experimental Vein Bypass Grafts with Verapamil Treatment

  1990cites this paper
• Inhibition by calcium channel blockers of the binding of platelet-activating factor to human neutrophil granulocytes.

  1990cites this paper
• Characterization of alpha 2-adrenoceptors in the rat: proximal tubule, renal membrane and whole kidney studies.

  1990cites this paper
• Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation.

  1989cites this paper
• [Effect of calcium-channel blockers on human thrombocyte aggregation induced by alpha-adrenoreceptor agonists].

  1989cites this paper
• Effects of growth factors on cytosolic free calcium concentration and DNA synthesis in cultured rat aortic smooth muscle cells.

  1989cites this paper
• Verapamil interacts in vitro with alpha 2-adrenoceptors but does not modify alpha 2-receptivity in vivo.

  1989cites this paper
• Effects of verapamil on reoxygenation and programmed electrical stimulation-induced ventricular arrhythmias in the isolated heart.

  1989cites this paper
• Phenylalkylamine-sensitive calcium channels in osteoblast-like osteosarcoma cells. Characterization by ligand binding and single channel recordings.

  1988cites this paper
• Cocaine‐induced ventricular fibrillation: protection afforded by the calcium antagonist verapamil

  1988cites this paper
• Dihydropyridine Agonist Bay K 8644 Inhibits Platelet Activation by Competitive Antagonism of Thromboxane A2‐Prostaglandin H2 Receptor

  1988cites this paper
• Effects of some calcium antagonists on aggregation by adrenalin and serotonin and on alpha-adrenoceptor radioligand binding in human platelets.

  1988cites this paper
• Die Rolle der Blutplättchen bei der Atherogenese und ihre Beeinflussung durch Ca ++ -Antagonisten

  1988cites this paper
• Ca-entry blockers, verapamil and diltiazem, on alpha 1-adrenoceptors in thoracic aorta, renal artery and portal vein from rabbit.

  1988cites this paper
• [Mechanisms of thrombocyte activation and possibilities of their pharmacological regulation].

  1988cites this paper
• Nephrocalcinosis Calcium Antagonists and Kidney

  1988cites this paper
• Additive competitive interaction of verapamil and quinidine at alpha-adrenergic receptors of isolated cardiac guinea pig myocytes and human platelets.

  1988cites this paper
• The Unique Chemical Composition of Nephrocalcinosis in Experimental Renal Insufficiency, Disturbances of Cellular Calcium Metabolism, and Protective Effect of Verapamil Against Nephrocalcinosis

  1988cites this paper
• Regulation of alpha-2 Adrenergic Receptors

  1988cites this paper
• Ca2+ Antagonists — Mode of Action and Pharmacodynamics

  1988cites this paper
• Quin2 microfluorometry and effects of verapamil and diltiazem on calcium release from rat aorta smooth muscle cells in primary culture.

  1988cites this paper
• Effect of superoxide and lipid peroxide on cytosolic free calcium concentration in cultured pig aortic endothelial cells.

  1988cites this paper
• Verapamil enhances the non-adrenergic twitch response of rat vas deferens.

  1987cites this paper
• Calcium antagonists in cerebral/peripheral vascular disorders. Current status.

  1987cites this paper
• Effects of verapamil and diltiazem on human platelet function.

  1987cites this paper
• Inhibition of platelet-activating factor binding to human platelets by calcium channel blockers.

  1987cites this paper
• Calcium Antagonists in Cerebral/Peripheral Vascular Disorders

  1987cites this paper
• Interactions of amiloride with alpha- and beta-adrenergic receptors: amiloride reveals an allosteric site on alpha 2-adrenergic receptors.

  1987cites this paper
• Can calcium antagonists affect the hemostatic mechanism and promote rebleeding? An experimental study.

  1987cites this paper
• A serial study of platelet reactivity throughout the first six months after myocardial infarction: its modification by sulphinpyrazone.

  1987cites this paper
• [Action of calcium antagonists on thrombocyte aggregation].

  1987cites this paper
• Competitive Interaction of Amiloride and Verapamil with α1 Adrenoceptors in Vascular Smooth Muscle

  1986cites this paper
• ATP-secretion occurs as an initial response in collagen induced platelet activation.

  1986cites this paper
• Calcium antagonism and calcium entry blockade.

  1986cites this paper
• Verapamil improves defective duodenal calcium absorption in experimental chronic renal failure.

  1986cites this paper
• Therapeutic uses of calcium channel-blocking drugs in the young.

  1986cites this paper
• Cardiovascular alpha 2-adrenoceptors.

  1986cites this paper
• Binding of [3H]prazosin to porcine aortic membranes: interaction of calcium antagonists with vascular alpha-1 adrenoceptors.

  1986cites this paper
• Modulation of lymphocyte adrenergic receptors by hormones and anti-asthmatic drugs.

  1985cites this paper
• Increase in human platelet alpha 2-adrenergic receptor affinity for agonist in unstable angina.

  1985cites this paper
• Epinephrine-Induced Aggregation of Rabbit Platelets Refractory to ADP

  1985cites this paper
• Receptors for Platelet Agonists

  1985cites this paper
• Mechanism and metabolic disposition of verapamil-evoked overflow of radioactivity from isolated atria preloaded with [3H]norepinephrine.

  1985cites this paper
• Do D 600 and diltiazem interact with serotonin receptors in rabbit vascular tissues?

  1985cites this paper
• Calcium antagonist affinity for adrenergic and cholinergic receptors in rabbit urinary bladder

  1985cites this paper
• Influence of calcium-channel blockers on platelet function and arachidonic acid metabolism.

  1985cites this paper
• Nifedipine and alpha 1-adrenergic blockade in Raynaud's phenomenon.

  1985cites this paper
• Klinische Pharmakologie II

  1984cites this paper
• Effects of verapamil on lipolysis due to dibutyryl cyclic AMP.

  1984cites this paper
• The role of Ca2+ uptake in the response of human platelets to adrenaline and to 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor).

  1984cites this paper
• Ca2+ homeostasis in unstimulated platelets.

  1984cites this paper
• Studies of the mechanism of noradrenaline stimulation of fluid absorption by rat jejunum in vitro.

  1984cites this paper
• Quinidine is a competitive antagonist at alpha 1- and alpha 2-adrenergic receptors.

  1984cites this paper
• Promising Uses of Calcium‐Channel Blocking Agents

  1984cites this paper
• Interference of calcium entry blockade in vivo with pressor responses to alpha-adrenergic stimulation: effects of two unrelated blockers on responses to both exogenous and endogenously released norepinephrine.

  1984cites this paper
• Influence of verapamil and diltiazem on aggregatory responses in cat and rabbit platelet rich plasma.

  1984cites this paper
• Differential effects of nifedipine, verapamil, and diltiazem on noradrenaline-induced contractions, adrenergic transmitter release, and alpha-adrenoceptor binding in the female rabbit urethra

  1984cites this paper
• Myocardial Micronecrosis Produced by Microsphere Embolization: Role of an α‐Adrenergic Tonic Influence on the Coronary Microcirculation

  1984cites this paper
• Role of platelet antagonists in coronary artery disease: implications in coronary artery bypass surgery and balloon-catheter dilatation.

  1984cites this paper
• Verapamil and Collagen-Induced Platelet Reactions- Evidence for a Role for Intracellular Calcium in Platelet Activation

  1983cites this paper
• Medical Treatment of Unstable Angina : Effects of Calcium Antagonists : Unstable Angina

  1983cites this paper
• [Pharmacology of anti-platelet agents].

  1983cites this paper
• Platelet Function Inhibitors

  1983cites this paper
• Effect of the Calcium-Entry Blocking Agent Nifedipine on Activation of Human Platelets and Comparison with Verapamil

  1983cites this paper
• Intracellular calcium ions in affective disorders: a review and an hypothesis.

  1983cites this paper
• Yohimbine: a pharmacological probe for study of the alpha 2-adrenoreceptor.

  1983cites this paper
• Calcium antagonists: a new class of drugs.

  1983cites this paper
• Effects of verapamil on platelet aggregation, ATP release and thromboxane generation.

  1983cites this paper
• A comparison of the effects of verapamil and cinnarizine upon responses elicited by selective alpha 1- and alpha 2-adrenoceptor agonists in the autoperfused canine hindlimb.

  1983cites this paper
• Adrenergic receptors in man: direct identification, physiologic regulation, and clinical alterations.

  1982cites this paper